ZACKS INVESTMENT MANAGEMENT

Position in INDV — Indivior Pharmaceuticals, Inc.

CIK 1086483 Chicago, IL

Position in INDV

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$594,237

+$354,025 QoQ

Shares Held

14,483

+83.8% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#185

of 334 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ZACKS INVESTMENT MANAGEMENT holds $9,127,553 across 4 Drug Manufacturers - Specialty & Generic names. INDV ranks #4 (6.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	20,271	$3,416,474
2	PAHC	Phibro Animal Health Corp	102,233	$3,210,116
3	COLL	Collegium Pharmaceutical, Inc	52,672	$1,906,726
4	INDV	Indivior Pharmaceuticals, Inc. This page	14,483	$594,237

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$594,237	14,483	+83.8%	Shares	Sole	2026-08-13
2026-03-31	$240,212	7,881	—	Shares	Sole	2026-05-14
No filing history on record for this holder in this stock.